Selecta Biosciences Inc. | Mutual Funds
Mutual Funds that own Selecta Biosciences Inc.
Vanguard Total Stock Market Index Fund
412,123
1.84%
0
0%
07/31/2018
iShares Russell 2000 ETF
376,802
1.68%
-201
0.01%
09/06/2018
Fidelity Select Biotechnology Portfolio
279,423
1.25%
0
0.04%
07/31/2018
JPMorgan US Small Companies Fund
251,900
1.12%
4,900
0.18%
07/31/2018
iShares Russell 2000 Growth ETF
176,982
0.79%
0
0.02%
09/06/2018
Candriam Equities L - Biotechnology
143,000
0.64%
0
0.14%
07/31/2018
Wasatch Micro Cap Fund
138,488
0.62%
-30,530
0.4%
03/31/2018
Vanguard Extended Market Index Fund
125,699
0.56%
0
0%
07/31/2018
Small Cap Value Fund
99,009
0.44%
0
5.51%
03/31/2018
Wasatch Ultra Growth Fund
60,427
0.27%
0
0.44%
03/31/2018
| Address |
480 Arsenal Way
Watertown Massachusetts 02472
United States
|
|
Employees
|
- |
| Website |
http://www.selectabio.com |
| Updated |
07/08/2019 |
| Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The firm produces the Synthetic Vaccine Particles (SVP) platform for immune tolerance and immune stimulation. Its proprietary pipeline includes SVP-enabled enzyme, oncology, and gene therapies. |
